<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 50-year-old woman with a history of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> developed cervical <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo> and atypical <z:hpo ids='HP_0100827'>lymphocytosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Atypical cells of lymph nodes were positive for CD3 and CD30 but negative for anaplastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> kinase (ALK) </plain></SENT>
<SENT sid="2" pm="."><plain>Bone marrow examination showed trilineage <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>She was diagnosed with ALK-negative anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>) with leukemic transformation and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) which presumably developed from <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was resistant to intensive chemotherapies, ultimately leading to <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Leukemic presentation of ALK-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> as an initial manifestation is extremely rare, and the progression of the disease may be influenced by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> through alteration of immune functions </plain></SENT>
</text></document>